Skip to content
Coya Therapeutics, Inc

Greenlight Capital Coya Therapeutics, Inc transactions over time

COYA

Coya Therapeutics, Inc historical holders

total: 1

Transactions details

Total transactions:
7
New positions:
1
Added:
6
Held for:
0 quarters
Latest activity:
2026 Q1
David Einhorn has been an institutional investor in Coya Therapeutics, Inc (COYA) since 2022 Q4. According to 2026 Q3 report, David Einhorn holds 2,335,540 shares with a market value of roughly $11.70M representing 0.33% of their equity portfolio. The fund/company first acquired COYA in 2022 Q4, initially purchasing 392,444 shares. Since the initial investment, Greenlight Capital has made 6 more transactions in this position.

Does David Einhorn still hold COYA?

Yes, David Einhorn continues to hold Coya Therapeutics, Inc (COYA). According to their 2026 Q3 report, they maintain a position of 2,335,540 shares valued at approximately $11.70M, representing 0.33% of their equity portfolio.

When did David Einhorn first invest in COYA?

David Einhorn first invested in Coya Therapeutics, Inc (COYA) in 2022 Q4 at the reported quarter-end price of $4.74 per share, acquiring 392,444 shares in their initial purchase.

COYA transactions history by Greenlight Capital

7 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q1
0.29%
2,335,540
$3.94
$9,202,027
+15.28% (+309,600)
+0.04%
2025 Q4
0.41%
2,025,940
$5.80
$11,750,452
+23.05% (+379,500)
+0.08%
2024 Q4
0.49%
1,646,440
$5.73
$9,434,101
+29.23% (+372,414)
+0.11%
2023 Q4
0.46%
1,274,026
$7.41
$9,440,533
+172.19% (+805,959)
+0.29%
2023 Q3
0.10%
468,067
$3.84
$1,797,377
+19.21% (+75,420)
+0.02%
2023 Q1
0.08%
392,647
$3.97
$1,560,183
+0.05% (+203)
+0%
2022 Q4
0.13%
392,444
$4.74
$1,859,439
new
+0.13%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.